0.89

0.46% -0.0041

After Hours: .92 0.03 +3.37%

Promis Neurosciences Inc (PMN)

Overview News Price History Financials Discussions Forecast Stock Split

Promis Neurosciences Inc stock is traded at $0.89, with a volume of 27,387. It is down -0.46% in the last 24 hours and down -1.17% over the past month. ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Previous Close:

$0.8941

Open:

$0.91

24h Volume:

27,387

Relative Volume:

0.38

Market Cap:

$28.93M

Revenue:

Net Income/Loss:

$-563.30K

P/E Ratio:

-4.4589

EPS:

-0.1996

Net Cash Flow:

$-22.23M

1W Performance:

-4.02%

1M Performance:

-1.17%

6M Performance:

-35.06%

1Y Performance:

-56.69%

1-Day Range:

$0.8801

$0.9399

1-Week Range:

$0.88

$1.02

52-Week Range:

$0.87

$2.61

Promis Neurosciences Inc Stock (PMN) Company Profile

Name

Promis Neurosciences Inc

Sector

Healthcare (1178)

Industry

Biotechnology (678)

Phone

416-847-6898

Address

SUITE 200, 1920 YONGE STREET, TORONTO

Employee

Twitter

Next Earnings Date

2024-11-12

Latest SEC Filings

PMN's Discussions on Twitter

Compare PMN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PMN Promis Neurosciences Inc	0.89	28.93M	0	-563.30K	-22.23M	-0.1996
VRTX Vertex Pharmaceuticals Inc	438.40	113.67B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	683.08	74.97B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	665.68	40.50B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	277.16	35.95B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	120.88	29.63B	3.30B	-501.07M	1.03B	-2.1146

Promis Neurosciences Inc Stock (PMN) Latest News

Jan 29, 2025

StockNews.com Initiates Coverage on Beasley Broadcast Group (NASDAQ:BBGI) - Defense World

Jan 29, 2025

Altimmune to Participate in the Guggenheim SMID Cap Biotech Conference - The Manila Times

Jan 29, 2025

ProMIS Neurosciences to Participate in Guggenheim Securities SMID Cap Biotech Conference - GlobeNewswire

Jan 29, 2025

ProMIS Neurosciences Updates Corporate Presentation in Recent 8-K Filing - Defense World

Jan 29, 2025

Vanda Pharmaceuticals Files for New Drug Application for Tradipitant for Motion Sickness Treatment - Defense World

Jan 29, 2025

Jan 27, 2025

ProMIS Neurosciences Initiates Phase 1b Clinical Trial (PRECISE-AD) in Alzheimer's Disease - The Manila Times

Jan 10, 2025

iTeos Announces 2025 Strategic Priorities and Anticipated Milestones - The Manila Times

Jan 10, 2025

ProMIS Neurosciences Initiates Phase 1b Clinical Trial (PRECISE-AD) in Alzheimer’s Disease - GlobeNewswire

Jan 10, 2025

Jan 09, 2025

ProMIS Neurosciences faces Nasdaq delisting over share price - Investing.com

Jan 09, 2025

Jan 02, 2025

Nonfat Dry Milk (DFZ25) Quote - The Globe and Mail

Jan 02, 2025

Dec 27, 2024

Berkshire Hathaway Cl B (BRK-B-N) QuotePress Release - The Globe and Mail

Dec 27, 2024

ProMIS Neurosciences (NASDAQ:PMN) Shares Up 2.8% – Should You Buy? - Defense World

Dec 27, 2024

Dec 19, 2024

ProMIS Neurosciences stock hits 52-week low at $0.88 By Investing.com - Investing.com Nigeria

Dec 19, 2024

Dec 18, 2024

ProMIS Neurosciences stock hits 52-week low at $0.88 - Investing.com

Dec 18, 2024

Dec 06, 2024

Vertiv Holdings Llc. (VRT-N) QuotePress Release - The Globe and Mail

Dec 06, 2024

Dec 02, 2024

ProMIS Neurosciences, Inc. (NASDAQ:PMN) Short Interest Down 16.6% in November - Defense World

Dec 02, 2024

Nov 26, 2024

ProMIS Neurosciences to Participate in 7th Annual Evercore HealthCONx Conference - GlobeNewswire

Nov 26, 2024

Nov 20, 2024

ProMIS Neurosciences stock hits 52-week low at $0.91 - Investing.com

Nov 20, 2024

ProMIS Neurosciences stock hits 52-week low at $0.91 By Investing.com - Investing.com Australia

Nov 20, 2024

Nov 16, 2024

ProMIS Neurosciences Announces Third Quarter Financial Results and Recent HighlightsOn November 14, 2024, ProMIS Neurosciences Inc. (Nasdaq: PMN) shared its financial outcomes for the third quarter ended September 30, 2024. The company provide - Defense World

Nov 16, 2024

Nov 15, 2024

ProMIS Neurosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 15, 2024

GREAT POINT PARTNERS LLC Acquires Shares in ProMIS Neurosciences Inc - GuruFocus.com

Nov 15, 2024